Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?

BACKGROUND: Our previous work on early PSA kinetics following prostate stereotactic body radiation therapy (SBRT) demonstrated that an initial rapid and then slow PSA decline may result in very low PSA nadirs. This retrospective study sought to evaluate the PSA nadir 5 years following SBRT for low-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataria, Shaan, Koneru, Harsha, Guleria, Shan, Danner, Malika, Ayoob, Marilyn, Yung, Thomas, Lei, Siyuan, Collins, Brian T., Suy, Simeng, Lynch, John H., Kole, Thomas, Collins, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522851/
https://www.ncbi.nlm.nih.gov/pubmed/28791252
http://dx.doi.org/10.3389/fonc.2017.00157

Ejemplares similares

Ejemplares similares